{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:52:13Z","timestamp":1791035533204,"version":"4.1.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ijantimicag.2013.08.004","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T17:02:00Z","timestamp":1378573320000},"page":"584-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Totally resistant tuberculosis: will antileprosy drugs be helpful?"],"prefix":"10.1016","volume":"42","author":[{"given":"Philippe","family":"Brouqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Million","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Drancourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Raoult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.08.004_bib0005","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10096-012-1787-3","article-title":"The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics","volume":"32","author":"Dubourg","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.08.004_bib0010","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/jac\/dkt089","article-title":"Ivermectin lacks antituberculous activity","volume":"68","author":"Muhammed Ameen","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.004_bib0015","doi-asserted-by":"crossref","first-page":"e63057","DOI":"10.1371\/journal.pone.0063057","article-title":"Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa","volume":"8","author":"Shean","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2013.08.004_bib0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/jac\/dkr501","article-title":"Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan","volume":"67","author":"Huang","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.004_bib0025","first-page":"725","article-title":"Achievement of sputum culture negative conversion by minocycline in a case with extensively drug-resistant pulmonary tuberculosis [in Japanese]","volume":"83","author":"Kawada","year":"2008","journal-title":"Kekkaku"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791300294X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791300294X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T09:02:18Z","timestamp":1539421338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791300294X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S092485791300294X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.08.004","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Totally resistant tuberculosis: will antileprosy drugs be helpful?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}